CXC chemokines located in the 4q21 region are up-regulated in breast cancer

Bieche, I., Chavey, C., Andrieu, C., Busson, M., Vacher, S., Le Corre, L., Guinebretiere, J.-M., Burlinchon, S. +2 more·2007·Endocrine Related Cancer

Cited by (183)

Items 101–183 of 183

  1. Transcription factor c-Myb inhibits breast cancer lung metastasis by suppression of tumor cell seeding
    Lucia Knopfová, Elisabetta Biglieri, Nataliya Volodko, Michal Masařík, Markéta Hermanová, Jesus Francisco Glaus Garzon, Monika Dúcka, Tereza Kučírková, Karel Souček, Jan Šmarda et al. · 2017 · Oncogene
  2. ADSCs stimulated by resistin promote breast cancer cell malignancy via CXCL5 in a breast cancer coculture model
    Yen‐Yun Wang, Amos C. Hung, Yi‐Chia Wu, Steven John Lo, Huan‐Da Chen, Yuk-Kwan Chen, Ya-Ching Hsieh, Stephen Chu‐Sung Hu, Ming‐Feng Hou, Shyng‐Shiou F. Yuan · 2022 · Scientific Reports
  3. Polymorphisms in Inflammation Pathway Genes and Endometrial Cancer Risk
    Ryan Delahanty, Yong‐Bing Xiang, Amanda B. Spurdle, Alicia C. Beeghly-Fadiel, Jirong Long, Deborah J. Thompson, Ian P.M. Tomlinson, Herbert Yu, Diether Lambrechts, Thilo Dörk et al. · 2012 · Cancer Epidemiology Biomarkers & Prevention
  4. Revisiting the CXCL13/CXCR5 axis in the tumor microenvironment in the era of single-cell omics: Implications for immunotherapy
    Xuanyu Gu, Dongyu Li, Peng Wu, Chaoqi Zhang, Xinyu Cui, Dexin Shang, Ruijie Ma, Jingjing Liu, Nan Sun, Jie He · 2024 · Cancer Letters
  5. Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines
    Xiaoqi Sun, Qunxi Chen, Lihong Zhang, Jiewei Chen, Xinke Zhang · 2021 · Mathematical Biosciences & Engineering
  6. RCAN1-mediated calcineurin inhibition as a target for cancer therapy
    Mengyi Lao, Xiaozhen Zhang, Hanshen Yang, Xueli Bai, Tingbo Liang · 2022 · Molecular Medicine
  7. The AGEs/RAGE Transduction Signaling Prompts IL-8/CXCR1/2-Mediated Interaction between Cancer-Associated Fibroblasts (CAFs) and Breast Cancer Cells
    Maria Francesca Santolla, Marianna Talia, Francesca Cirillo, Domenica Scordamaglia, Salvatore De Rosis, Asia Spinelli, Anna Miglietta, Bruno Nardo, Gianfranco Filippelli, Ernestina Marianna De Francesco et al. · 2022 · Cells
  8. Cancer-Associated Stemness and Epithelial-to-Mesenchymal Transition Signatures Related to Breast Invasive Carcinoma Prognostic
    Iulia-Monica Groza, Cornelia Braicu, Ancuta Maria Jurj, Oana Zănoagă, Lajos Ráduly, Paul Adrian Chiroi, Roxana Cojocneanu, Diana Loreta Păun, Alexandru Irimie, Schuyler Safi Korban et al. · 2020 · Cancers
  9. Overexpression of chemokine ligand 7 is associated with the progression of canine transmissible venereal tumor
    Hsin-Chien Chiang, Yu‐Shan Wang, Chung‐Hsi Chou, Albert Taiching Liao, Rea‐Min Chu, Chen‐Si Lin · 2012 · BMC Veterinary Research
  10. XCL 1‐ XCR 1 pathway promotes trophoblast invasion at maternal‐fetal interface by inducing MMP ‐2/ MMP ‐9 activity
    Si‐Ming Zhang, Fu‐Ju Tian, Weihong Zeng, Xiaoling Ma, Jiabin Ren, Yi Lin · 2018 · American Journal of Reproductive Immunology
  11. The adhesion-GPCR ADGRF5 fuels breast cancer progression by suppressing the MMP8-mediated antitumorigenic effects
    Yalan Wu, Huixia Liu, Zhe Sun, Jieling Liu, Kai Li, Ronghui Fan, Fujun Dai, Hui Tang, Qi Hou, Jinsong Li et al. · 2024 · Cell Death and Disease
  12. Prognostic and clinicopathological significance of CXCL1 in cancers: a systematic review and meta-analysis
    Zulei Zhang, Yuting Chen, Yaofei Jiang, Yan Luo, Hao Zhang, Yakun Zhan · 2019 · Cancer Biology & Therapy
  13. Clinical significance and biological functions of chemokine CXCL3 in head and neck squamous cell carcinoma
    Jian Guan, Jinru Weng, Qiaosheng Ren, Chunbin Zhang, Lian-Tao Hu, Wenjun Deng, Shizhen Lu, Xinyu Dong, Weidong Li, Yue Li et al. · 2021 · Bioscience Reports
  14. The interconnected role of chemokines and estrogen in bone metabolism
    Yingping Xu, Nan Chu, Xuemin Qiu, Hans-Jürgen Gober, Da‐Jin Li, Ling Wang · 2016 · BioScience Trends
  15. A niche that triggers aggressiveness within BRCA1-IRIS overexpressing triple negative tumors is supported by reciprocal interactions with the microenvironment
    Daniel Ryan, Abhilasha Sinha, Danielle R. Bogan, Joanna Davida Davies, Jim Koziol, Wael M. ElShamy · 2017 · Oncotarget
  16. Plasma CXCL3 Levels Are Associated with Tumor Progression and an Unfavorable Colorectal Cancer Prognosis
    Can Cui, Rui Zhang, Feng Gu, Yunfeng Pei, Li Sun, Yueyang Huang, Guoping Niu, Jian Li · 2022 · Journal of Immunology Research
  17. The role of CXCR3 and its ligands in renal transplant outcome
    Shahriar Dabiri, Ashraf Kariminik, Derek D. Kennedy · 2016 · European Cytokine Network
  18. Tumor suppressive lncRNA MEG3 binds to EZH2 and enhances CXCL3 methylation in gallbladder cancer
    De-Qiang Li, Yi-Ren Ding, Jin-Hui Che, Zhan Su, Wei-Zhong Yang, Lu Xu, Yun-Jiu Li, Hai-Hong Wang, Wu-Yuan Zhou · 2022 · Neoplasma
  19. Plac1 Is a Key Regulator of the Inflammatory Response and Immune Tolerance In Mammary Tumorigenesis
    Hongyan Yuan, Xiaoyi Wang, Chunmei Shi, Lü Jin, Jianxia Hu, Alston Zhang, James Li, Nairuthya Vijayendra, Venkata Doodala, Spencer Weiss et al. · 2018 · Scientific Reports
  20. Detection of epigenetic field defects using a weighted epigenetic distance-based method
    Ya Wang, Min Qian, Peifeng Ruan, Andrew Erich Teschendorff, Shuang Wang · 2018 · Nucleic Acids Research
  21. Letrozole-induced functional changes in carcinoma-associated fibroblasts and their influence on breast cancer cell biology
    Kaifu Li, Hua Kang, Yajun Wang, Hai Tao, Guohua Rong, Haichen Sun · 2016 · Medical Oncology
  22. Insights on CXC chemokine receptor 2 in breast cancer: An emerging target for oncotherapy (Review)
    Fengzhu Guo, Lang Long, Jiantao Wang, Yuyi Wang, Yanyang Liu, Li Wang, Feng Luo · 2019 · Oncology Letters
  23. Modulating Properties of Piroxicam, Meloxicam and Oxicam Analogues against Macrophage-Associated Chemokines in Colorectal Cancer
    Paulina Lewandowska, Izabela Szczuka, Iwona S Bednarz-Misa, Berenika Marta Szczęśniak-Sięga, Katarzyna Neubauer, Magdalena Mierzchała-Pasierb, Marek Zawadzki, Wojciech Witkiewicz, Małgorzata Krzystek‐Korpacka · 2021 · Molecules
  24. Molecular mechanism of gossypol mediating CCL2 and IL‑8 attenuation in triple‑negative breast cancer cells
    Samia S. Messeha, Najla O. Zarmouh, Patricia Mendonca, Carolyn Cotton, Karam F. A. Soliman · 2020 · Molecular Medicine Reports
  25. Using evasins to target the chemokine network in inflammation
    Shoumo Bhattacharya, Akane Kawamura · 2019 · Advances in protein chemistry and structural biology
  26. CXCL3 overexpression affects the malignant behavior of oral squamous cell carcinoma cells via the MAPK signaling pathway
    Jinru Weng, Qiaosheng Ren, Zhehao Li, Weiqun Wang, Jian Guan · 2021 · Journal of Oral Pathology and Medicine
  27. Bioengineering Embryonic Stem Cell Microenvironments for the Study of Breast Cancer
    Nurazhani Abdul Raof, Bridget Mooney, Yubing Xie · 2011 · International Journal of Molecular Sciences
  28. Identification and validation of a T cell marker gene-based signature to predict prognosis and immunotherapy response in gastric cancer
    Jinlin Zhong, Rong-ling Pan, Miao Gao, Yuqian Mo, Xin Peng, Guoxiao Liang, Zixuan Chen, Jinlin Du, Zhigang Huang · 2023 · Scientific Reports
  29. The health status alters the pituitary function and reproduction of mice in aCxcr2-dependent manner
    Colin Timaxian, Isabelle Raymond‐Letron, Céline Bouclier, Linda Gulliver, Ludovic Le Corre, Karim Chébli, Anne Guillou, Patrice Mollard, Karl Balabanian, Gwendal Lazennec · 2020 · Life Science Alliance
  30. Exploring breast carcinogenesis through integrative genomics and epigenomics analyses
    Minning Chin, Norfilza Mohd Mokhtar, Norlia Abdullah, Rohaizak Muhammad, Nor Aina Emran, Siti Aishah Md Ali, Roslan Harun, Rahman Jamal · 2014 · International Journal of Oncology
  31. Opticin, a small leucine-rich proteoglycan, is uniquely expressed and translocated to the nucleus of chronic lymphocytic leukemia cells
    Eva Mikaelsson, Anders Österborg, Zahra Tahmasebi Fard, Ahmad Reza Mahmoudi, Jafar Mahmoudian, Mahmood Jeddi‐Tehrani, Mohammad Mehdi Akhondi, Fazel Shokri, Paul N Bishop, Hodjattallah Rabbani et al. · 2013 · Experimental Hematology and Oncology
  32. Molecular Pathology of Cancer Metastasis: Suggestions for Future Therapy
    Adriano Angelucci, Edoardo Alesse · 2012 · Humana Press eBooks
  33. Age-related and postmenopausal breast cancer progression and treatment management: The significance of pro-inflammatory cytokines and CXC chemokines
    Amin Ullah, Rajeev Kumar Singla, Dan Cao, Boyang Chen, Bairong Shen · 2025 · Genes & Diseases
  34. A screen for short-range paracrine interactions
    Katrina H. Spencer, M. Y. Kim, Christopher C.W. Hughes, Elliot E. Hui · 2014 · Integrative Biology
  35. Comprehensive Analysis of Prognostic Microenvironment-Related Genes in Invasive Breast Cancer
    Yingrong Shi, Si Chen, Huijuan Xing, Guanglie Jiang, Nan Wu, Qiannan Liu, Norihiro Sakamoto, Takayoshi Kuno, Reiko Sugiura, Qinghuan Xiao et al. · 2022 · Frontiers in Oncology
  36. Spatial analyses revealed CXCL5 and SLC6A14 as the markers of microvascular invasion in intrahepatic cholangiocarcinoma
    Guangyu Fan, Liyuan Dai, Tongji Xie, Lin Li, Le Min Tang, Xiaohong Han, Yuankai Shi · 2024 · Hepatology Communications
  37. Aberrantly expressed mRNAs and long non-coding RNAs in patients with invasive ductal breast carcinoma: A pilot study
    XUEDONG CHEN, Jingyun Yang, Liyuan Qian, TIANZHU CAO · 2014 · Molecular Medicine Reports
  38. Prognostic and tumor-immune infiltration cell signatures in tamoxifen-resistant breast cancers
    Zhenyu Cao, Ziwei Jin, Liyun Zeng, Hongye He, Qitong Chen, Qiongyan Zou, Dengjie Ouyang, Na Luo, Yulong Zhang, Yunchang Yuan et al. · 2021 · Gland Surgery
  39. Interleukin 8 in progression of hormone-dependent early breast cancer
    Jelena Milovanović, Nataša Todorović‐Raković, Tijana Vujasinović, Zaki Abu Rabi · 2017 · Journal of Biosciences
  40. CXCL1 in triple‑negative breast cancer: Mechanisms, challenges, and therapeutic opportunities (Review)
    Hiba Al Sayegh, Zahraa Assi, Amjad Kanaan, Mirvat El‐Sibai · 2026 · Oncology Reports
  41. Association of High Expression of Groβwith Clinical and Pathological Characteristics of Unfavorable Prognosis in Gastrointestinal Stromal Tumors
    Hui Zhao, Huijun Zhu, Qin Jin, Shu Zhang, Wei Wang, Defeng Wang, Jianfei Huang · 2015 · Disease Markers
  42. Immunostimulatory and Anti-inflammatory Effect of Ganoderma Lucidum on Breast Cancer Patients
    Nidhal A. K. Mohammed Ali, Hakar Abdulkareem Saeed, Ramadhan T. Othman · 2018 · Asian Pacific Journal of Cancer Biology
  43. CXCL12–CXCR4 Axis in Cancer Metastasis
    Manzoor Ahmad Mir, Ab Qayoom Naik, Mohd Zahoor ul haq Shah, Tabassum Zafar · 2023 · Springer eBooks
  44. CXC ELR-Positive Chemokines as Diagnostic and Prognostic Markers for Breast Cancer Patients
    Joanna Motyka, Aleksandra Kicman, Monika Kulesza, Sławomir Ławicki · 2023 · Cancers
  45. Global transcriptomic analysis of breast cancer and normal mammary epithelial cells infected with Borrelia burgdorferi
    Vishwa A. Khatri, Sambuddha Paul, Niraj Jatin Patel, Sahaja Thippani, Janhavi Y. Sawant, Katie L. Durkee, Cassandra L. Murphy, Geneve Ortiz Aleman, Justine A. Valentino, Jasmine Jathan et al. · 2023 · European Journal of Microbiology and Immunology
  46. Breast Cancer Cells Induce a Pro-inflammatory Response to Mitigate Immune Mediation in a 3D Culture Model
    Tanya Nadine Augustine, Raquel A. B. Duarte, Geoffrey Patrick Candy · 2020 · Anticancer Research
  47. Roles of Chemokine Axes in Breast Cancer
    Deok‐Soo Son, Samuel Evans Adunyah · 2024 · Frontiers in Bioscience-Landmark
  48. Tumor-derived CXCL5 promotes 5-fluorouracil resistance in colorectal cancer cells via p21 downregulation
    Wanjun Xu, Jianjun Wang, Wencan Han, Jinmin Sun, Xuemei Yang, Xiaomin Li, Dong‐Sheng Pei · 2025 · Medical Oncology
  49. Unveiling the mechanistic role of the Aryl hydrocarbon receptor in environmentally induced Breast cancer
    Prarthana Chatterjee, Satarupa Banerjee · 2023 · Biochemical Pharmacology
  50. Molecular and functional characterization of tumor-induced factor (TIF): Hamster homolog of CXCL3 (GROγ) displays tumor suppressive activity
    Lili Jin, Zhou‐Fang Li, Da‐Kui Wang, Meina Sun, Wei Qi, Qiang Ma, Li Zhang, Chun Chu, Elaine Y. M. Chan, Susanna S.T. Lee et al. · 2017 · Cytokine
  51. CXCL13-CXCR5 axis:regulation in inflammatory diseases and cancer
    wang binhan, Manni Wang, Danyi Ao, Xiawei Wei · 2022 · Research Square
  52. Detection of Epigenetic Field Defects Using a Weighted Epigenetic Distance-Based Method
    Ya Wang, Min Qian, Peifeng Ruan, Andrew Erich Teschendorff, Shuang Wang · 2020 · Methods in molecular biology
  53. Liver resection modulates hepatic chemokine levels in breast cancer
    Hilmi Anıl Dinçer, Utku Horzum, M. Alper Kursunel, Diğdem Yöyen-Ermiş, Erkan Ermiş, Ece Özoğul, Nezih Akkapulu, Güneş Esendağlı, Derya Karakoç · 2023 · Surgery
  54. Roles of Chemokines in Influencing Tumor Microenvironment in Breast Cancer
    Deok‐Soo Son, Samuel Evans Adunyah · 2024 · IntechOpen eBooks
  55. Intervention of IL-8-CXCR2 axis to reverse the resistance to GBM therapies
    Kartik Angara, Mohammad H. Rashid, Ali S. Arbab · 2021 · Elsevier eBooks
  56. Mechanisms of glioblastoma resistance to antiangiogenic agents and reversal approaches
    Kartik Angara, Ali S. Arbab · 2021 · Elsevier eBooks
  57. Neonatal administration of synthetic estrogen, diethylstilbestrol to mice up-regulates inflammatory Cxclchemokines located in the 5qE1 region in the vaginal epithelium
    Ayaka Kitamura, Jiayue Chen, Tomoya Suwa, Yasuhiko Kato, Tadashi Wada, Hajime Watanabe · 2023 · PLoS ONE
  58. Exploration of Prognostic Biomarkers and Therapeutic Targets in The Microenvironment of Bladder Cancer Based on CXC Chemokines
    Xiaoqi Sun, Qunxi Chen, Lihong Zhang, Jiewei Chen, Xinke Zhang · 2021 · Research Square
  59. Acute myeloid leukemia : apoptotic signalling and gene expression associated with treatment response
    Marita Lagergren Lindberg · 2013 · Figshare
  60. Adipocyte-Induced Inflammation In Prostate Tumor Progression In Bone: Role Of Cxcr2 And Osteopontin
    Aimalie Hardaway · 2015 · Human Biology
  61. Inflammatory Mediators as Therapeutic Targets for Inflammatory Breast Cancer
    Fredika M. Robertson, Khoi Chu, Rita Circo, Julia Dianne Wulfkuhle, L. A. Liotta, Annie Z. Luo, Kimberly M. Boley, Erik M. Freiter, Hui Liu, Pijus Kumar Mandal et al. · 2012 · Springer eBooks
  62. The role of myeloid cells in breast cancer metastasis
    Agnieszka Swierczak · 2012 · Minerva Access (University of Melbourne)
  63. Over-expression of CXCR4, a stemness enhancer, in human blastocysts by low level laser irradiation
    Mohammad Hossein Tahmasbi, Mohammad Shafiee, Mohammad Taghi Joghataei, Seyed Amir Yazdanparast, Seyed Akbar Moosavi, Mina Naghi Jafarabadi, Masoud Soleimani · 2013 · Research in Molecular Medicine
  64. Acute myeloid leukemia - Apoptotic signalling and gene expression associated with treatment response
    Leif Stenke, Lena Kanter, Bjørn Tore Gjertsen, Universitetet Bergen, Docent Sören Lehmann, Catharina Larsson, Bengt Smedmyr · 2013
  65. Cytokines and Breast Cancer
    Jonna M. Frasor · 2011 · Science Publishers eBooks
  66. Restriction and characterization of human breast cancer using a three-dimensional embryonic stem cell model
    Bridget Mooney · 2016
  67. ACTIVATION OF MACROPHAGES IN VIVO BY GLYCAN LNFPIII
    Mikayla Thompson · 2008 · Digital WPI
  68. Statistical Methods for Epigenetic Data
    Ya Wang · 2019
  69. Analyse der Expression von Chemokinen und Chemokinrezeptoren in Kopf-Hals-Tumorzellen
    David Rolke · 2018
  70. The Age-Dependent Characterization of the ER-Alpha Positive Breast Cancer Tumor Microenvironment
    K. Hamel · 2021
  71. Exploration of Prognostic Biomarkers and Therapeutic Targets in The Microenvironment of Bladder Cancer Based on CXC Chemokines
    Xiaoqi Sun, Qunxi Chen, Lihong Zhang, Jiewei Chen, Xinke Zhang · 2021 · Research Square
  72. Exploration of Prognostic Biomarkers and Therapeutic Targets in The Microenvironment of Bladder Cancer Based on CXC Chemokines
    Xiaoqi Sun, Qunxi Chen, Lihong Zhang, Jiewei Chen, Xinke Zhang · 2021 · Research Square
  73. Exploration of Prognostic Biomarkers and Therapeutic Targets in The Microenvironment of Bladder Cancer Based on CXC Chemokines
    Xiaoqi Sun, Qunxi Chen, Lihong Zhang, Jiewei Chen, Xinke Zhang · 2021 · Research Square
  74. Exploration of Prognostic Biomarkers and Therapeutic Targets in The Microenvironment of Bladder Cancer Based on CXC Chemokines
    Xiaoqi Sun, Qunxi Chen, Lihong Zhang, Jiewei Chen, Xinke Zhang · 2021 · Research Square
  75. Avaliação de quimiocinas circulantes em pacientes com câncer de mama, o ardiloso luminal b e as misteriosas quimiocinas
    Rogério Araújo · 2023
  76. XIAOSHUI formula inhibits malignant pleural effusion by targeting the STC1/p65/CXCL5 axis to reprogram tumor-associated macrophages
    Shan Ge, Runzhi Qi, Yu Zhang, Yuwei Zhao, Jingyang Wei, Qi Huang, Fen Liu, Xinmei Miao, Baojin Hua, Jun Liang et al. · 2026 · Phytomedicine
  77. Rôle des chimiokines dans les interactions entre les cellules stromales mésenchymateuses et les cellules de cancer du sein
    Pauline Arias Escobar · 2010
  78. Implication de zonula occludens-1 dans les processus pro-inflammatoires associés à la progression métastatique des cancers broncho-pulmonaires
    Déborah Neyrinck-Leglantier · 2018
  79. Identification de biomarqueurs pronostiques des tumeurs du carrefour bilio-pancréatique
    Fabien Robin · 2022
  80. Unraveling escape and metastasis mechanisms in triple negative breast cancer following chemotherapy treatment
    Amina Naït Eldjoudi · 2023 · theses.fr (ABES)
  81. Human NKG2C+ adaptive NK cells for Cancer immunotherapy
    Qiao Tang, Zhigang Tian, Jiacheng Bi · 2026 · International Immunopharmacology
  82. CXCL3 deficiency ameliorates COPD by suppressing cigarette smoke–induced NETs formation via MAPK signaling
    Yun Zhou, Qiancheng Xu, Yuxing Wang, Jinxiong Wu, Qian Li, Huimei Wu, Yeshan Li, Xiaoyun Fan · 2026 · Molecular Immunology
  83. Tpl2 (MAP3K8) regulates the migration, differentiation, and function of critical innate immune cells during the inflammatory response
    Sean M. Rowley · 2012